AmiSight 11/3: Weight-Loss Drugs Putting Big Strain on Employer Insurance Costs
- Ami Kassar

- 4 days ago
- 1 min read
Weight-loss drugs certainly are popular – but they may be driving up insurance costs for employers, potentially cutting into employment and wage growth.
The Wall Street Journal reports that the cost of health insurance rose steeply for a third year in a row in 2025, reaching just under $27,000 for a family plan, according to an annual survey from the nonprofit KFF.
Chronic diseases, the rising rate of cancer and hospital bills continue to drive up the price, but employers are seeing increased outlays on new and costly therapies, particularly the popular drugs known as GLP-1s, a category that includes the weight-loss treatments Wegovy and Zepbound.
This is resulting in employers pushing more of the burden onto workers by boosting out-of-pocket charges such as deductibles and copayments. Some small businesses are even pulling the plug on providing health insurance due to the skyrocketing costs.
Webinars of the Week: November 5 & 6
Wednesday, Nov 5 | 12:00 – 12:45 PM ET
Ami Kassar: What Banks Miss: Strategic Borrowing for Entrepreneurs
Is Your Bank Holding You Back From Your Dream Loan? Your bank might be limiting your options without you even knowing it. There's a better way to get the funding you need.
Thursday, Nov 6 | 12:00 – 12:45 PM ET
Lynn Ozer: Equity Essentials for Acquisitions & Start-Ups
Equity can be a powerful tool — if you know how to use it. Lynn will break down how you can structure equity effectively, avoid common pitfalls, and make smart funding decisions from the start.







Comments